Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives

The cyclooxygenase-2 (COX-2) enzyme is an important target for drug discovery and development of novel anti-inflammatory agents. Selective COX-2 inhibitors have the advantage of reduced side-effects, which result from COX-1 inhibition that is usually observed with nonselective COX inhibitors. In thi...

Full description

Bibliographic Details
Main Authors: Katharigatta N. Venugopala, Sandeep Chandrashekharappa, Christophe Tratrat, Pran Kishore Deb, Rahul D. Nagdeve, Susanta K. Nayak, Mohamed A. Morsy, Pobitra Borah, Fawzi M. Mahomoodally, Raghu Prasad Mailavaram, Mahesh Attimarad, Bandar E. Aldhubiab, Nagaraja Sreeharsha, Anroop B. Nair, Osama I. Alwassil, Michelyne Haroun, Viresh Mohanlall, Pottathil Shinu, Rashmi Venugopala, Mahmoud Kandeel, Belakatte P. Nandeshwarappa, Yasmine F. Ibrahim
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/12/3550
id doaj-a93033df97874456b6deecfd06366840
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Katharigatta N. Venugopala
Sandeep Chandrashekharappa
Christophe Tratrat
Pran Kishore Deb
Rahul D. Nagdeve
Susanta K. Nayak
Mohamed A. Morsy
Pobitra Borah
Fawzi M. Mahomoodally
Raghu Prasad Mailavaram
Mahesh Attimarad
Bandar E. Aldhubiab
Nagaraja Sreeharsha
Anroop B. Nair
Osama I. Alwassil
Michelyne Haroun
Viresh Mohanlall
Pottathil Shinu
Rashmi Venugopala
Mahmoud Kandeel
Belakatte P. Nandeshwarappa
Yasmine F. Ibrahim
spellingShingle Katharigatta N. Venugopala
Sandeep Chandrashekharappa
Christophe Tratrat
Pran Kishore Deb
Rahul D. Nagdeve
Susanta K. Nayak
Mohamed A. Morsy
Pobitra Borah
Fawzi M. Mahomoodally
Raghu Prasad Mailavaram
Mahesh Attimarad
Bandar E. Aldhubiab
Nagaraja Sreeharsha
Anroop B. Nair
Osama I. Alwassil
Michelyne Haroun
Viresh Mohanlall
Pottathil Shinu
Rashmi Venugopala
Mahmoud Kandeel
Belakatte P. Nandeshwarappa
Yasmine F. Ibrahim
Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives
Molecules
indolizine derivatives
molecular modeling
COX-2 inhibition
crystal structure
Hirshfeld surface analysis
energy framework
author_facet Katharigatta N. Venugopala
Sandeep Chandrashekharappa
Christophe Tratrat
Pran Kishore Deb
Rahul D. Nagdeve
Susanta K. Nayak
Mohamed A. Morsy
Pobitra Borah
Fawzi M. Mahomoodally
Raghu Prasad Mailavaram
Mahesh Attimarad
Bandar E. Aldhubiab
Nagaraja Sreeharsha
Anroop B. Nair
Osama I. Alwassil
Michelyne Haroun
Viresh Mohanlall
Pottathil Shinu
Rashmi Venugopala
Mahmoud Kandeel
Belakatte P. Nandeshwarappa
Yasmine F. Ibrahim
author_sort Katharigatta N. Venugopala
title Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives
title_short Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives
title_full Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives
title_fullStr Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives
title_full_unstemmed Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives
title_sort crystallography, molecular modeling, and cox-2 inhibition studies on indolizine derivatives
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2021-06-01
description The cyclooxygenase-2 (COX-2) enzyme is an important target for drug discovery and development of novel anti-inflammatory agents. Selective COX-2 inhibitors have the advantage of reduced side-effects, which result from COX-1 inhibition that is usually observed with nonselective COX inhibitors. In this study, the design and synthesis of a new series of 7-methoxy indolizines as bioisostere indomethacin analogues (<b>5a</b>–<b>e</b>) were carried out and evaluated for COX-2 enzyme inhibition. All the compounds showed activity in micromolar ranges, and the compound diethyl 3-(4-cyanobenzoyl)-7-methoxyindolizine-1,2-dicarboxylate (<b>5a</b>) emerged as a promising COX-2 inhibitor with an IC<sub>50</sub> of 5.84 µM, as compared to indomethacin (IC<sub>50</sub> = 6.84 µM). The molecular modeling study of indolizines indicated that hydrophobic interactions were the major contribution to COX-2 inhibition. The title compound diethyl 3-(4-bromobenzoyl)-7-methoxyindolizine-1,2-dicarboxylate (<b>5c</b>) was subjected for single-crystal X-ray studies, Hirshfeld surface analysis, and energy framework calculations. The X-ray diffraction analysis showed that the molecule (<b>5c</b>) crystallizes in the monoclinic crystal system with space group <i>P</i> 2<sub>1</sub>/n with <i>a</i> = 12.0497(6)Å, <i>b</i> = 17.8324(10)Å, <i>c</i> = 19.6052(11)Å, <i>α</i> = 90.000°, <i>β</i> = 100.372(1)°, <i>γ</i> = 90.000°, and V = 4143.8(4)Å<sup>3</sup>. In addition, with the help of <i>Crystal Explorer</i> software program using the B3LYP/6-31G(d, p) basis set, the theoretical calculation of the interaction and graphical representation of energy value was measured in the form of the energy framework in terms of coulombic, dispersion, and total energy.
topic indolizine derivatives
molecular modeling
COX-2 inhibition
crystal structure
Hirshfeld surface analysis
energy framework
url https://www.mdpi.com/1420-3049/26/12/3550
work_keys_str_mv AT katharigattanvenugopala crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT sandeepchandrashekharappa crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT christophetratrat crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT prankishoredeb crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT rahuldnagdeve crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT susantaknayak crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT mohamedamorsy crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT pobitraborah crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT fawzimmahomoodally crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT raghuprasadmailavaram crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT maheshattimarad crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT bandarealdhubiab crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT nagarajasreeharsha crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT anroopbnair crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT osamaialwassil crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT michelyneharoun crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT vireshmohanlall crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT pottathilshinu crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT rashmivenugopala crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT mahmoudkandeel crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT belakattepnandeshwarappa crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
AT yasminefibrahim crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives
_version_ 1721350356261142528
spelling doaj-a93033df97874456b6deecfd063668402021-06-30T23:50:52ZengMDPI AGMolecules1420-30492021-06-01263550355010.3390/molecules26123550Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine DerivativesKatharigatta N. Venugopala0Sandeep Chandrashekharappa1Christophe Tratrat2Pran Kishore Deb3Rahul D. Nagdeve4Susanta K. Nayak5Mohamed A. Morsy6Pobitra Borah7Fawzi M. Mahomoodally8Raghu Prasad Mailavaram9Mahesh Attimarad10Bandar E. Aldhubiab11Nagaraja Sreeharsha12Anroop B. Nair13Osama I. Alwassil14Michelyne Haroun15Viresh Mohanlall16Pottathil Shinu17Rashmi Venugopala18Mahmoud Kandeel19Belakatte P. Nandeshwarappa20Yasmine F. Ibrahim21Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi ArabiaDepartment of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER-R) Raebareli, Lucknow UP 226002, IndiaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi ArabiaFaculty of Pharmacy, Philadelphia University, Amman 19392, JordanDepartment of Chemistry, Visvesvaraya National Institute of Technology, Nagpur 440010, Maharashtra, IndiaDepartment of Chemistry, Visvesvaraya National Institute of Technology, Nagpur 440010, Maharashtra, IndiaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi ArabiaPratiksha Institute of Pharmaceutical Sciences, Chandrapur Road, Panikhaiti, Guwahati 781026, Assam, IndiaDepartment of Health Sciences, Faculty of Medicine and Health Sciences, University of Mauritius, Réduit 80835, MauritiusDepartment of Pharmaceutical Chemistry, Shri Vishnu College of Pharmacy, Vishnupur, Bhimavaram 534202, IndiaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi ArabiaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi ArabiaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi ArabiaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi ArabiaDepartment of Pharmaceutical Sciences, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi ArabiaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi ArabiaDepartment of Biotechnology and Food Technology, Durban University of Technology, Durban 4001, South AfricaDepartment of Biomedical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi ArabiaDepartment of Public Health Medicine, Howard College Campus, University of KwaZulu-Natal, Durban 4001, South AfricaDepartment of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-Ahsa 31982, Saudi ArabiaDepartment of Studies in Chemistry, Shivagangotri, Davangere University, Davangere, Karnataka 577007, IndiaDepartment of Pharmacology, Faculty of Medicine, Minia University, El-Minia 61511, EgyptThe cyclooxygenase-2 (COX-2) enzyme is an important target for drug discovery and development of novel anti-inflammatory agents. Selective COX-2 inhibitors have the advantage of reduced side-effects, which result from COX-1 inhibition that is usually observed with nonselective COX inhibitors. In this study, the design and synthesis of a new series of 7-methoxy indolizines as bioisostere indomethacin analogues (<b>5a</b>–<b>e</b>) were carried out and evaluated for COX-2 enzyme inhibition. All the compounds showed activity in micromolar ranges, and the compound diethyl 3-(4-cyanobenzoyl)-7-methoxyindolizine-1,2-dicarboxylate (<b>5a</b>) emerged as a promising COX-2 inhibitor with an IC<sub>50</sub> of 5.84 µM, as compared to indomethacin (IC<sub>50</sub> = 6.84 µM). The molecular modeling study of indolizines indicated that hydrophobic interactions were the major contribution to COX-2 inhibition. The title compound diethyl 3-(4-bromobenzoyl)-7-methoxyindolizine-1,2-dicarboxylate (<b>5c</b>) was subjected for single-crystal X-ray studies, Hirshfeld surface analysis, and energy framework calculations. The X-ray diffraction analysis showed that the molecule (<b>5c</b>) crystallizes in the monoclinic crystal system with space group <i>P</i> 2<sub>1</sub>/n with <i>a</i> = 12.0497(6)Å, <i>b</i> = 17.8324(10)Å, <i>c</i> = 19.6052(11)Å, <i>α</i> = 90.000°, <i>β</i> = 100.372(1)°, <i>γ</i> = 90.000°, and V = 4143.8(4)Å<sup>3</sup>. In addition, with the help of <i>Crystal Explorer</i> software program using the B3LYP/6-31G(d, p) basis set, the theoretical calculation of the interaction and graphical representation of energy value was measured in the form of the energy framework in terms of coulombic, dispersion, and total energy.https://www.mdpi.com/1420-3049/26/12/3550indolizine derivativesmolecular modelingCOX-2 inhibitioncrystal structureHirshfeld surface analysisenergy framework